SWOT Analysis for RPG Life Sciences Ltd.

Add SWOT widget to your site/app

Companies with no Debt
Strong Momentum: Price above short, medium and long term moving averages
Upcoming results for Nifty500 companies with previous quarter net profit growth greater than 10% YoY and QoQ
Consistent Highest Return Stocks over Five Years
Strong QoQ EPS Growth in recent results
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing Revenue every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
MACD crossed above zero line previous end of day
Top Gainers
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

Companies with no Debt

Strong Momentum: Price above short, medium and long term moving averages

Upcoming results for Nifty500 companies with previous quarter net profit growth greater than 10% YoY and QoQ

Consistent Highest Return Stocks over Five Years

Strong QoQ EPS Growth in recent results

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Results Screener: Stocks with upcoming results which are seeing positive shifts in share price

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

RSI indicating price strength

MACD crossed above zero line previous end of day

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Increasing Trend in Non-Core Income
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Companies with growing costs YoY for long term projects

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Increasing Trend in Non-Core Income

Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

Companies with Upcoming Results
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
Weekly Momentum Gainers
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months

Companies with Upcoming Results

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

Weekly Momentum Gainers

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Expensive Performers (DVM)
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Expensive Performers (DVM)

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

RPG Life Sciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

RPG Life Sciences Ltd. has 26 Strengths, 6 Weaknesses, 7 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential